{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:39:04Z","timestamp":1793479144553,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Objective:<\/jats:title>\n                    <jats:p>Obstructive sleep apnea (OSA) is a common condition, featured by repetitive upper airway collapse during sleep manifested with poor quality of life and co-morbidities. Although continuous positive airway pressure (CPAP) is the recommended therapy, lack of patient compliance and persistent symptoms often preclude its success. The present study evaluates the effect of acetazolamide in combination with CPAP, and compares this treatment strategy to single therapy using CPAP in moderate to severe OSA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A parallel-group, open-label randomized controlled trial consisted of 95 subjects diagnosed with moderate to severe OSA. Subjects were randomly allocated in a 1:1 ratio to CPAP plus acetazolamide (C+D) and CPAP alone (C). The baseline characteristics and the apnea-hypopnea index (AHI) metrics were comparable. Following four weeks of intervention, the outcomes measured involved changes in AHI (apnea hypopnoea index), sleep architecture, ODI (oxygen desaturation Index), and other sleep parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The combination of CPAP and acetazolamide significantly reduced total AHI (34.69 \u00b1 18.91 events\/hour) compared to CPAP alone (45.47 \u00b1 19.09 events\/hour,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0044). AHI also observed significant improvements during non-REM sleep (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0014). Although no significant difference was found in AHI during REM sleep between the groups (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.6284), the C+D group demonstrated a notable decrease in severe OSA cases and an increase in mild and moderate OSA classifications. Compliance-adjusted AHI was significantly lower in the C+D group (5.67 \u00b1 3.45) compared to the C group (7.67 \u00b1 3.41,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0034). The C+D group exhibited improved sleep architecture with lower percentages of N1 and N3 sleep stages, and a trend towards increased REM sleep percentage (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0704). Significant reductions in WASO (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0404) and ODI (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.0301) were also observed. Both groups reported minimal and comparable side effects, indicating the safety and tolerability of the combination therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The addition of acetazolamide to CPAP therapy improves efficacy in OSA treatment parameters among moderate-to-severe OSA, reduces total and NREM AHI as well as ODI without an increase in adverse effects. With added pharmacotherapy, the combination therapy represents a potential adjunctive treatment for managing OSA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/lungindia.lungindia_409_24","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T13:00:23Z","timestamp":1735045223000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Comparing standard treatment of moderate to severe obstructive sleep apnoea to add-on acetazolamide treatment: An open-label randomised controlled trial"],"prefix":"10.4103","volume":"42","author":[{"given":"Anurag","family":"Tripathi","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Arif","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrityunjaya","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhra","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, King George\u2019s Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2231-0770.94803","article-title":"Obstructive sleep apnea-hypopnea syndrome: Etiology and diagnosis","volume":"2","author":"Sankri-Tarbichi","year":"2012","journal-title":"Avicenna J Med"},{"key":"R2-20241224","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000988","article-title":"Obstructive sleep apnea and cardiovascular disease: A scientific statement from the american heart association","volume":"144","author":"Yeghiazarians","year":"2021","journal-title":"Circulation"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir Med"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.2020.3514","article-title":"Diagnosis and management of obstructive sleep apnea: A review","volume":"323","author":"Gottlieb","year":"2020","journal-title":"JAMA"},{"key":"R6-20241224","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1164\/rccm.201303-0448OC","article-title":"Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets","volume":"188","author":"Eckert","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1164\/ajrccm.163.5.2007013","article-title":"Chemical control stability in patients with obstructive sleep apnea","volume":"163","author":"Younes","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1183\/09031936.00158413","article-title":"Zonisamide reduces obstructive sleep apnoea: A randomized placebo-controlled study","volume":"44","author":"Eskandari","year":"2014","journal-title":"Eur Respir J"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5664\/jcsm.6968","article-title":"Acetazolamide reduces blood pressure and sleep-disordered breathing in patients with hypertension and obstructive sleep apnea: A randomized controlled trial","volume":"14","author":"Eskandari","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"R10-20241224","doi-asserted-by":"crossref","first-page":"e12956","DOI":"10.1111\/jsr.12956","article-title":"Carbonic anhydrase, obstructive sleep apnea and hypertension: Effects of intervention","volume":"29","author":"Hoff","year":"2020","journal-title":"J Sleep Res"},{"key":"R11-20241224","first-page":"CD001106","article-title":"Continuous positive airways pressure for obstructive sleep apnoea in adults","author":"Giles","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1164\/rccm.202109-2043OC","article-title":"L. A randomized controlled clinical trial exploring safety and tolerability of sulthiame in sleep apnea","volume":"205","author":"Hedner","year":"2022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Lung India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/lungindia.lungindia_409_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:18Z","timestamp":1786647258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/lungindia.lungindia_409_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/lungindia.lungindia_409_24","relation":{},"ISSN":["0970-2113","0974-598X"],"issn-type":[{"value":"0970-2113","type":"print"},{"value":"0974-598X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"2024-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}